Plain-English translation of NCT07281040 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This is a preparatory study—not a treatment trial itself—that gathers feedback from healthcare providers and people with heart failure about potential new treatments that could be added to diuretic therapy (water pills). Researchers want to understand which treatments seem most promising and acceptable before launching a larger clinical trial.
When patients are hospitalized with heart failure, doctors often use diuretics to help remove excess fluid, but many patients still struggle. This study exists to find out which additional treatments might help and whether hospitals would be willing and able to test them in a proper clinical trial.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would complete an online survey where you share your thoughts and experiences about different treatment options. The survey takes place online through a secure platform and asks for your feedback on which treatments seem acceptable and helpful. This is purely an information-gathering step to help researchers design a better trial in the future.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom
Hull University Teaching Hospitals NHS Trust
Collaborators
Hull York Medical School, University of Birmingham
Enrollment target
~10 participants
Started
July 2025
Primary completion
October 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Joe Cuthbert, MBBS MD
Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Cottingham Road, Kingston-Upon-Hull, HU6 7RX
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.